ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer

Background - Financial toxicity, defined as both the objective financial burden and subjective financial distress from a cancer diagnosis and its treatment, is a topic of interest in the assessment of the quality of life of patients with cancer and their families. Current evidence implicates financi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Carrera, Pricivel M. (VerfasserIn) , Curigliano, G. (VerfasserIn) , Santini, D. (VerfasserIn) , Sharp, L. (VerfasserIn) , Chan, R. J. (VerfasserIn) , Pisu, M. (VerfasserIn) , Perrone, F. (VerfasserIn) , Karjalainen, S. (VerfasserIn) , Numico, G. (VerfasserIn) , Cherny, N. (VerfasserIn) , Winkler, Eva C. (VerfasserIn) , Amador, M. L. (VerfasserIn) , Fitch, M. (VerfasserIn) , Lawler, M. (VerfasserIn) , Meunier, F. (VerfasserIn) , Khera, N. (VerfasserIn) , Pentheroudakis, G. (VerfasserIn) , Trapani, D. (VerfasserIn) , Ripamonti, C. I. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: May 2024
In: ESMO open
Year: 2024, Jahrgang: 9, Heft: 5, Pages: 1-15
ISSN:2059-7029
DOI:10.1016/j.esmoop.2024.102992
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.esmoop.2024.102992
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S2059702924007609
Volltext
Verfasserangaben:P.M. Carrera, G. Curigliano, D. Santini, L. Sharp, R.J. Chan, M. Pisu, F. Perrone, S. Karjalainen, G. Numico, N. Cherny, E. Winkler, M.L. Amador, M. Fitch, M. Lawler, F. Meunier, N. Khera, G. Pentheroudakis, D. Trapani & C.I. Ripamonti

MARC

LEADER 00000caa a2200000 c 4500
001 1909632341
003 DE-627
005 20241220171151.0
007 cr uuu---uuuuu
008 241127s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.esmoop.2024.102992  |2 doi 
035 |a (DE-627)1909632341 
035 |a (DE-599)KXP1909632341 
035 |a (OCoLC)1475648365 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Carrera, Pricivel M.  |e VerfasserIn  |0 (DE-588)1349489158  |0 (DE-627)1909633534  |4 aut 
245 1 0 |a ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer  |c P.M. Carrera, G. Curigliano, D. Santini, L. Sharp, R.J. Chan, M. Pisu, F. Perrone, S. Karjalainen, G. Numico, N. Cherny, E. Winkler, M.L. Amador, M. Fitch, M. Lawler, F. Meunier, N. Khera, G. Pentheroudakis, D. Trapani & C.I. Ripamonti 
264 1 |c May 2024 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar 15 April 2024, Version des Artikels 15 April 2024 
500 |a Gesehen am 27.11.2024 
520 |a Background - Financial toxicity, defined as both the objective financial burden and subjective financial distress from a cancer diagnosis and its treatment, is a topic of interest in the assessment of the quality of life of patients with cancer and their families. Current evidence implicates financial toxicity in psychosocial, economic and other harms, leading to suboptimal cancer outcomes along the entire trajectory of diagnosis, treatment, supportive care, survivorship and palliation. This paper presents the results of a virtual consensus, based on the evidence base to date, on the screening and management of financial toxicity in patients with and beyond cancer organized by the European Society for Medical Oncology (ESMO) in 2022. - Methods - A Delphi panel of 19 experts from 11 countries was convened taking into account multidisciplinarity, diversity in health system contexts and research relevance. The international panel of experts was divided into four working groups (WGs) to address questions relating to distinct thematic areas: patients with cancer at risk of financial toxicity; management of financial toxicity during the initial phase of treatment at the hospital/ambulatory settings; financial toxicity during the continuing phase and at end of life; and financial risk protection for survivors of cancer, and in cancer recurrence. After comprehensively reviewing the literature, statements were developed by the WGs and then presented to the entire panel for further discussion and amendment, and voting. - Results and discussion - A total of 25 evidence-informed consensus statements were developed, which answer 13 questions on financial toxicity. They cover evidence summaries, practice recommendations/guiding statements and policy recommendations relevant across health systems. These consensus statements aim to provide a more comprehensive understanding of financial toxicity and guide clinicians globally in mitigating its impact, emphasizing the importance of further research, best practices and guidelines. 
650 4 |a assessment tools 
650 4 |a cancer 
650 4 |a financial toxicity 
650 4 |a health insurance coverage 
650 4 |a sociodemographic factors 
650 4 |a survivorship 
700 1 |a Curigliano, G.  |e VerfasserIn  |4 aut 
700 1 |a Santini, D.  |e VerfasserIn  |4 aut 
700 1 |a Sharp, L.  |e VerfasserIn  |4 aut 
700 1 |a Chan, R. J.  |e VerfasserIn  |4 aut 
700 1 |a Pisu, M.  |e VerfasserIn  |4 aut 
700 1 |a Perrone, F.  |e VerfasserIn  |4 aut 
700 1 |a Karjalainen, S.  |e VerfasserIn  |4 aut 
700 1 |a Numico, G.  |e VerfasserIn  |4 aut 
700 1 |a Cherny, N.  |e VerfasserIn  |4 aut 
700 1 |a Winkler, Eva C.  |d 1971-  |e VerfasserIn  |0 (DE-588)1055853065  |0 (DE-627)792734823  |0 (DE-576)411905384  |4 aut 
700 1 |a Amador, M. L.  |e VerfasserIn  |4 aut 
700 1 |a Fitch, M.  |e VerfasserIn  |4 aut 
700 1 |a Lawler, M.  |e VerfasserIn  |4 aut 
700 1 |a Meunier, F.  |e VerfasserIn  |4 aut 
700 1 |a Khera, N.  |e VerfasserIn  |4 aut 
700 1 |a Pentheroudakis, G.  |e VerfasserIn  |4 aut 
700 1 |a Trapani, D.  |e VerfasserIn  |4 aut 
700 1 |a Ripamonti, C. I.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t ESMO open  |d [London] : Elsevier, 2016  |g 9(2024), 5 vom: Mai, Artikel-ID 102992, Seite 1-15  |h Online-Ressource  |w (DE-627)84705344X  |w (DE-600)2844985-X  |w (DE-576)454658516  |x 2059-7029  |7 nnas  |a ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer 
773 1 8 |g volume:9  |g year:2024  |g number:5  |g month:05  |g elocationid:102992  |g pages:1-15  |g extent:15  |a ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer 
856 4 0 |u https://doi.org/10.1016/j.esmoop.2024.102992  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S2059702924007609  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20241127 
993 |a Article 
994 |a 2024 
998 |g 1055853065  |a Winkler, Eva C.  |m 1055853065:Winkler, Eva C.  |d 910000  |d 912900  |d 50000  |e 910000PW1055853065  |e 912900PW1055853065  |e 50000PW1055853065  |k 0/910000/  |k 1/910000/912900/  |k 0/50000/  |p 11 
999 |a KXP-PPN1909632341  |e 4623149617 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer","title_sort":"ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer"}],"language":["eng"],"person":[{"family":"Carrera","display":"Carrera, Pricivel M.","role":"aut","given":"Pricivel M."},{"family":"Curigliano","display":"Curigliano, G.","role":"aut","given":"G."},{"given":"D.","role":"aut","display":"Santini, D.","family":"Santini"},{"role":"aut","given":"L.","display":"Sharp, L.","family":"Sharp"},{"given":"R. J.","role":"aut","display":"Chan, R. J.","family":"Chan"},{"family":"Pisu","display":"Pisu, M.","role":"aut","given":"M."},{"family":"Perrone","display":"Perrone, F.","role":"aut","given":"F."},{"display":"Karjalainen, S.","role":"aut","given":"S.","family":"Karjalainen"},{"family":"Numico","given":"G.","role":"aut","display":"Numico, G."},{"given":"N.","role":"aut","display":"Cherny, N.","family":"Cherny"},{"display":"Winkler, Eva C.","role":"aut","given":"Eva C.","family":"Winkler"},{"family":"Amador","display":"Amador, M. L.","given":"M. L.","role":"aut"},{"family":"Fitch","display":"Fitch, M.","given":"M.","role":"aut"},{"display":"Lawler, M.","role":"aut","given":"M.","family":"Lawler"},{"display":"Meunier, F.","role":"aut","given":"F.","family":"Meunier"},{"given":"N.","role":"aut","display":"Khera, N.","family":"Khera"},{"display":"Pentheroudakis, G.","given":"G.","role":"aut","family":"Pentheroudakis"},{"family":"Trapani","display":"Trapani, D.","role":"aut","given":"D."},{"role":"aut","given":"C. I.","display":"Ripamonti, C. I.","family":"Ripamonti"}],"name":{"displayForm":["P.M. Carrera, G. Curigliano, D. Santini, L. Sharp, R.J. Chan, M. Pisu, F. Perrone, S. Karjalainen, G. Numico, N. Cherny, E. Winkler, M.L. Amador, M. Fitch, M. Lawler, F. Meunier, N. Khera, G. Pentheroudakis, D. Trapani & C.I. Ripamonti"]},"id":{"doi":["10.1016/j.esmoop.2024.102992"],"eki":["1909632341"]},"physDesc":[{"extent":"15 S."}],"relHost":[{"name":{"displayForm":["European Society for Medical Oncology"]},"physDesc":[{"extent":"Online-Ressource"}],"disp":"ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancerESMO open","id":{"zdb":["2844985-X"],"issn":["2059-7029"],"eki":["84705344X"]},"corporate":[{"role":"isb","display":"European Society for Medical Oncology"}],"note":["Gesehen am 13.06.24"],"origin":[{"publisherPlace":"[London] ; London","dateIssuedKey":"2016","dateIssuedDisp":"2016-","publisher":"Elsevier ; BMJ"}],"recId":"84705344X","type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"subtitle":"cancer horizons","title":"ESMO open","title_sort":"ESMO open"}],"part":{"year":"2024","text":"9(2024), 5 vom: Mai, Artikel-ID 102992, Seite 1-15","volume":"9","issue":"5","pages":"1-15","extent":"15"},"language":["eng"],"pubHistory":["1.2016 -"]}],"note":["Online verfügbar 15 April 2024, Version des Artikels 15 April 2024","Gesehen am 27.11.2024"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1909632341","origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"May 2024"}]} 
SRT |a CARRERAPRIESMOEXPERT2024